SciBase Holding AB | Income Statement

Fiscal year is January-December. All values SEK Thousands.
2014
2015
2016
2017
Sales/Revenue
1,600.00
4,151.00
6,436.00
6,859.00
Cost of Goods Sold (COGS) incl. D&A
2,499.00
4,218.00
4,516.00
5,046.00
Gross Income
899.00
67.00
1,920.00
1,813.00
SG&A Expense
38,242.00
41,957.00
53,087.00
44,168.00
EBIT
39,141.00
42,024.00
51,167.00
42,355.00
Non Operating Income/Expense
215.00
473.00
1,921.00
109.00
Pretax Income
38,865.00
41,532.00
53,085.00
42,464.00
Income Tax
110.00
-
1.00
-
Consolidated Net Income
38,755.00
41,532.00
53,086.00
42,464.00
Net Income
38,755.00
41,532.00
53,086.00
42,464.00
Net Income After Extraordinaries
38,755.00
41,532.00
53,086.00
42,464.00
Net Income Available to Common
38,755.00
41,532.00
53,086.00
42,464.00
EPS (Basic)
0.19
5.94
6.34
5.00
Basic Shares Outstanding
201,703.60
6,991.10
8,382.20
8,493.00
EPS (Diluted)
0.19
5.94
6.33
5.00
Diluted Shares Outstanding
201,703.60
6,991.10
8,382.20
8,493.00
EBITDA
38,819.00
41,854.00
50,835.00
41,742.00
Non-Operating Interest Income
61.00
19.00
3.00
-

About SciBase Holding AB

View Profile
Address
Kammakargatan 22
Stockholm AB 111 40
Sweden
Employees -
Website http://www.scibase.se
Updated 09/14/2018
SciBase Holding AB is a medical technology company, which engages in the development of instruments for the detection of skin cancer and other skin conditions. Its product includes Nevisense, which is a diagnostic support tool for non-visual detection of malignant melanoma. The company was founded by Stig Gösta Ollmar in 1998 and is headquartered in Stockholm, Sweden.